Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Obsidian Therapeutics
1030 Massachusetts Avenue, Suite 400
Cambridge, MA 02138
http://obsidiantx.com/

Obsidian Therapeutics is a biotechnology company developing next-generation cell and gene therapies with pharmacologic operating systems. Based upon founding work on destabilizing domains by Professor Thomas Wandless, a leading researcher in chemical and systems biology, Obsidian's lead programs are CAR-T products that incorporate controllable functions for enhanced safety and efficacy. Obsidian was founded in 2015 by Atlas Venture and is funded by a strong syndicate of venture investors.

Key Contact
NameTitleE-Mail
Michael GilmanCEO


Funding Events
DateAmountTypeInvestors
12/06/17$49,500,000Series A Alexandria Real Estate Equities
Amgen Ventures
Atlas Venture
Google Ventures  
ShangPharma Investment Group
Takeda Ventures
Vertex Ventures
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.